Table 2.

Introduction of meningococcal vaccines in the national vaccination programs and changes over time.

Country		First introduction of IMD vaccine*		Updates
BE	2002	1 dose at 15 months of age	2019	Switch from MenC to MenACWY for toddlers at 15 months of age Addition of booster dose of MenACWY vaccine for adolescents (15–16 years of age), with catch-up until 19 years of age
DE	2006	1 dose at 12 months of age Catch-up until 18 years of age	–
ES	2000	3 doses: 2, 4 and 6 months of age Catch-up until 19 years of age	2005	Replacement of the MenC dose at 4 months of age by a dose at 12–18 months of age
			2013	Change from 2 MenC doses at 2 and 6 months of age to 1 dose at 4 months of age Addition of booster dose of MenC vaccine for adolescents (12 years of age), with catch-up until 18 years of age
			2019	Switch from MenC to MenACWY for the booster dose at 12 years of age
FR	2010	1 dose at 12 months of age	2017	Addition of 1 MenC dose at 5 months of age
		Catch-up until 24 years of age	2022	Addition of MenB for infants and toddlers (3, 5, and 12 months of age)
IT	2012	1 dose at 13–15 months of age Catch-up from 11 to 18 years of age	2017	Addition of booster dose of MenACWY vaccine for adolescents (12–18 years of age) Addition of MenB for infants and toddlers (3, 4, 6, and 13 months of age)
NL	2002	1 dose at 14 months of age Catch-up until 18 years of age	2019	Switch from MenC to MenACWY for toddlers at 14 months of age Addition of booster dose of MenACWY vaccine for adolescents (14 years of age), with catch-up until 18 years of age
PT	2006	1 dose at 3, 5, and 15 months of age	2012	Replacement of the MenC dose at 3,5, and 15 months of age by a dose at 12 months of age
			2020	Addition of MenB for infants and toddlers (2, 4, and 12 months of age)
UK	1999	3 doses at 2, 3 and 4 months of age, respectively	2006	Replacement of the dose at 2 months of age by a dose at 12–13 months of age, with catch-up until 25 years of age
		Catch-up until 18 years of age	2013	Removal of MenC dose at 4 months of age, with catch-up for toddlers until 5 years of age Addition of booster dose of MenC vaccine for adolescents (13–14 years of age), with catch-up until 25 years of age
			2015	Switch from MenC to MenACWY for the adolescent booster dose at 13–14 years of age Addition of MenB for infants and toddlers (2, 4, and 12 months of age)
			2016	Removal of the MenC dose at 3 months of age

BE, Belgium; DE, Germany; ES, Spain; FR, France; IMD, invasive meningococcal disease; IT, Italy; Men, meningococcal vaccine; NL, Netherlands; PT, Portugal; UK, United Kingdom; –, Not applicable.

^*MenC was the first meningococcal vaccine introduced in the vaccination program of all countries.

In italics, addition of MenB in the national immunization program.